These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27853753)

  • 1. Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection.
    Huaman MA; Deepe GS; Fichtenbaum CJ
    Pathog Immun; 2016; 1(2):291-303. PubMed ID: 27853753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.
    Huaman MA; Henson D; Rondan PL; Ticona E; Miranda G; Kryscio RJ; Mugruza R; Aranda E; Ticona C; Abarca S; Heredia P; Aguirre A; Sterling TR; Garvy BA; Fichtenbaum CJ
    PLoS One; 2018; 13(9):e0202191. PubMed ID: 30212453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study.
    Lee JK; Lee HW; Heo EY; Yim JJ; Kim DK
    J Infect Chemother; 2021 Dec; 27(12):1694-1699. PubMed ID: 34412980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
    Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
    BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    Kim OH; Jo KW; Park S; Jo YH; Kim MN; Sung H; Shim TS
    PLoS One; 2020; 15(6):e0234700. PubMed ID: 32544206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive rate and risk factors of latent tuberculosis infection among persons living with HIV in Jiangsu Province, China.
    Zhang Y; Lu P; Wu K; Zhou H; Yu H; Yuan J; Dong L; Liu Q; Lu W; Yang H; Cao D; Zhu L
    Front Cell Infect Microbiol; 2023; 13():1051060. PubMed ID: 36960041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
    Doan TN; Eisen DP; Rose MT; Slack A; Stearnes G; McBryde ES
    PLoS One; 2017; 12(11):e0188631. PubMed ID: 29182688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV).
    Pettit AC; Stout JE; Belknap R; Benson CA; Séraphin MN; Lauzardo M; Horne DJ; Garfein RS; Maruri F; Ho CS;
    Clin Infect Dis; 2021 Oct; 73(7):e2278-e2284. PubMed ID: 32761083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.
    Petruccioli E; Chiacchio T; Navarra A; Vanini V; Cuzzi G; Cimaglia C; Codecasa LR; Pinnetti C; Riccardi N; Palmieri F; Antinori A; Goletti D
    J Infect; 2020 May; 80(5):536-546. PubMed ID: 32097688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.
    Kaplan SR; Escudero JN; Mecha J; Richardson BA; Maleche-Obimbo E; Matemo D; Kinuthia J; John-Stewart GC; LaCourse SM
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):98-107. PubMed ID: 34629414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda.
    Stein CM; Nsereko M; Malone LL; Okware B; Kisingo H; Nalukwago S; Chervenak K; Mayanja-Kizza H; Hawn TR; Boom WH
    Clin Infect Dis; 2019 May; 68(10):1705-1712. PubMed ID: 30165605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.